BSEResultResults4 Nov 2026
Swastika Castal Ltd
Unadited Financial Results for the half year ended on 30th September, 2026.
Swastika Castal Ltd has announced its unaudited financial results for the half year ended on 30th September, 2026, showing a profit of Rs. 170.99 lakhs and earnings per equity share of Rs. 2.09.
NSECopy of Newspaper PublicationResults4 Nov 2026
Glass Wall Systems (India) Limited
Copy of Newspaper Publication
Glass Wall Systems (India) Limited has published its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in The Free Press Journal and Navshakti newspapers.
BSEBoard MeetingResults4 Nov 2026
Computer Point Ltd
Computer Point Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Board Meeting is Scheduled to be held on 11th November,2026 at to consider and Adopt the Unaudited Financial Results for the Quarter and Half Year Ended 30.09.2026
Computer Point Ltd has scheduled a Board Meeting on 11th November, 2026 to consider and approve the Unaudited Financial Results for the Quarter and Half Year Ended 30.09.2026.
BSEResultResults4 Nov 2026
Redington Ltd
Financial Results - Q2 & H1 FY 2026-27
Redington Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with revenue from operations at ₹25,224.83 crore and ₹42,946.91 crore respectively.
BSECompany Update▲ PositiveResults4 Nov 2026
Exide Industries Ltd
Please find enclosed letter w.r.t. Press Release : H1 FY27 Revenue growth 18.9%, PAT growth 46.7%. Sustained momentum in Q2.
6 GWh of Lithium-ion Cell Gigafactory Commissioned.
Exide Industries Ltd reported H1 FY27 revenue growth of 18.9% and PAT growth of 46.7%, with a strong Q2 performance driven by healthy demand and cost optimisation initiatives.
NSEInvestor Presentation▲ PositiveResults4 Nov 2026
Marksans Pharma Limited
Investor Presentation
Marksans Pharma Limited has informed the Exchange about Investor Presentation for Q2FY27, with revenue reaching ₹940 crore, up 30.5% YoY, and EBITDA growing 48.3% to a record ₹214 crore.
BSECompany UpdateResults4 Nov 2026
Sandesh Ltd
Copy of Newspaper Publication
Sandesh Ltd has published its unaudited financial results for the quarter and half year ended September 30, 2026, in newspapers and on its website.
BSEBoard MeetingResults4 Nov 2026
Meghmani Organics Ltd
Meghmani Organics Limited has submitted to the Exchange, the financial results for the Second quarter and half year ended on 30.09.2026.
Meghmani Organics Ltd has submitted its unaudited financial results for the second quarter and half year ended September 30, 2026, with a standalone net profit of ₹4,532.16 crore and a comprehensive income of ₹4,555.76 crore.
BSEBoard MeetingResults4 Nov 2026
Lasa Supergenerics Ltd
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026 inter alia;
1. ....
Lasa Supergenerics Ltd has scheduled a Board Meeting on November 14, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.
BSECorp. ActionResults4 Nov 2026
Dr. Lal PathLabs Ltd
Attached
Dr. Lal PathLabs Ltd announced its un-audited financial results for the quarter and half year ended September 30, 2026, declaring a 2nd interim dividend of INR 5 per equity share. The company also appointed Ms. Vasuta Agarwal as an Additional Director and approved further investment of up to INR 49.5 Crores in its subsidiary Dr. Lal PathLabs FZCO.
BSEResultResults4 Nov 2026
Technopack Polymers Ltd
Unaudited Financial Results alongwith Limited Review Report of the Company for the half year ended on September 30, 2026
Technopack Polymers Ltd has announced unaudited financial results for the half year ended September 30, 2026, with the company's Board of Directors approving the results in a meeting held on November 4, 2026. The results show a total equity and liabilities of Rs. 2491.12 crores as of September 30, 2026, with a share capital of Rs. 1080 crores and reserves and surplus of Rs. 1091.37 crores.
BSEBoard MeetingResults4 Nov 2026
GPT Infraprojects Ltd
Please find enclosed herewith Outcome of the Board Meeting dated November 4, 2026
GPT Infraprojects Ltd has announced its un-audited financial results for the 2nd quarter and half year ended September 30, 2026, with a 1% interim dividend declared at Rs. 1 per equity share. The company has also approved the incorporation of a limited liability partnership (LLP) named Ever Strong Highway LLP.
BSECompany UpdateResults4 Nov 2026
Jtekt India Ltd
Announcemnet under Regulation 30
Jtekt India Ltd has announced unaudited financial results for the second quarter ended 30th September, 2026, and approved a proposal to invest up to Rs. 2,40,00,000 in a Special Purpose Vehicle for a Group Captive Solar Power Project.
NSECopy of Newspaper PublicationResults4 Nov 2026
Goyal Aluminiums Limited
Copy of Newspaper Publication
Goyal Aluminiums Limited has informed the Exchange about the submission of newspaper advertisement pertaining to Un-Audited Financial Results for the quarter and half year ended 30th September, 2026.
BSEResultResults4 Nov 2026
Marksans Pharma Ltd
Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2026
Marksans Pharma Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, with the Board of Directors approving the results at its meeting held on November 4, 2026. The results are available on the company's website.
NSEOutcome of Board MeetingResults4 Nov 2026
Rolex Rings Limited
Outcome of Board Meeting
Rolex Rings Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors and reviewed by the Audit Committee.
BSECorp ActionResults4 Nov 2026
Dr. Lal PathLabs Ltd
Attached
Dr. Lal PathLabs Ltd has announced its un-audited financial results for the quarter and half year ended September 30, 2026, along with the declaration of a 2nd interim dividend of INR 5 per equity share. The company has also appointed Ms. Vasuta Agarwal as an Additional Director and made further investments in its subsidiary company.
BSEResultResults4 Nov 2026
Century Plyboards (India) Ltd-$
Unaudited Financial Results for the quarter and half year ended 30th September, 2026
Century Plyboards (India) Ltd has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, showing a net profit of ₹100.08 crore and ₹1,002.26 crore respectively.
BSEResultResults4 Nov 2026
Simmonds Marshall Ltd
Simmonds Marshall Limited has submitted Unaudited Financial Results for the Quarter and half year ended September 30, 2026.
Simmonds Marshall Ltd has submitted unaudited financial results for the quarter and half year ended September 30, 2026, showing revenue from operations of Rs. 6,970.59 lakhs and profit for the period of Rs. 499.21 lakhs.
NSEOutcome of Board MeetingResults4 Nov 2026
Dr. Lal Path Labs Ltd.
Outcome of Board Meeting
Dr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026, where the Board of Directors considered, noted and approved the un-audited financial results for the quarter and half year ended September 30, 2026, declared 2nd interim dividend of INR 5/- per equity share, appointed Ms. Vasuta Agarwal as an Additional Director, and approved further investment in Dr. Lal PathLabs FZCO, a Wholly Owned Subsidiary of the Company.